rs12636577
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001690.4(ATP6V1A):c.-13-81A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.344 in 654,768 control chromosomes in the GnomAD database, including 40,181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.33 ( 8529 hom., cov: 32)
Exomes 𝑓: 0.35 ( 31652 hom. )
Consequence
ATP6V1A
NM_001690.4 intron
NM_001690.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.267
Publications
5 publications found
Genes affected
ATP6V1A (HGNC:851): (ATPase H+ transporting V1 subunit A) This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c", and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This encoded protein is one of two V1 domain A subunit isoforms and is found in all tissues. Transcript variants derived from alternative polyadenylation exist. [provided by RefSeq, Jul 2008]
ATP6V1A Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy 93Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal recessive cutis laxa type 2DInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Genomics England PanelApp, Ambry Genetics
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive cutis laxa type 2, classic typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 3-113778660-A-G is Benign according to our data. Variant chr3-113778660-A-G is described in ClinVar as Benign. ClinVar VariationId is 1268535.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.354 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP6V1A | NM_001690.4 | c.-13-81A>G | intron_variant | Intron 1 of 14 | ENST00000273398.8 | NP_001681.2 | ||
| ATP6V1A | XM_047448305.1 | c.-13-81A>G | intron_variant | Intron 1 of 14 | XP_047304261.1 | |||
| ATP6V1A | XM_047448306.1 | c.-13-81A>G | intron_variant | Intron 2 of 15 | XP_047304262.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.332 AC: 50476AN: 151908Hom.: 8532 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
50476
AN:
151908
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.348 AC: 174975AN: 502742Hom.: 31652 AF XY: 0.344 AC XY: 90344AN XY: 262424 show subpopulations
GnomAD4 exome
AF:
AC:
174975
AN:
502742
Hom.:
AF XY:
AC XY:
90344
AN XY:
262424
show subpopulations
African (AFR)
AF:
AC:
3406
AN:
11010
American (AMR)
AF:
AC:
2738
AN:
12032
Ashkenazi Jewish (ASJ)
AF:
AC:
3119
AN:
12570
East Asian (EAS)
AF:
AC:
10583
AN:
26054
South Asian (SAS)
AF:
AC:
5949
AN:
28114
European-Finnish (FIN)
AF:
AC:
18549
AN:
40176
Middle Eastern (MID)
AF:
AC:
538
AN:
1890
European-Non Finnish (NFE)
AF:
AC:
121711
AN:
344932
Other (OTH)
AF:
AC:
8382
AN:
25964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
5404
10808
16213
21617
27021
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2094
4188
6282
8376
10470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.332 AC: 50476AN: 152026Hom.: 8529 Cov.: 32 AF XY: 0.332 AC XY: 24694AN XY: 74298 show subpopulations
GnomAD4 genome
AF:
AC:
50476
AN:
152026
Hom.:
Cov.:
32
AF XY:
AC XY:
24694
AN XY:
74298
show subpopulations
African (AFR)
AF:
AC:
12658
AN:
41470
American (AMR)
AF:
AC:
3813
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
857
AN:
3470
East Asian (EAS)
AF:
AC:
1882
AN:
5174
South Asian (SAS)
AF:
AC:
1030
AN:
4822
European-Finnish (FIN)
AF:
AC:
4760
AN:
10538
Middle Eastern (MID)
AF:
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24333
AN:
67962
Other (OTH)
AF:
AC:
647
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1743
3487
5230
6974
8717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
872
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.